Jupiter Neurosciences Inc. Recorded Big Gain
Thu, Dec 12, 2024 at 07:10 PM
Jupiter Neurosciences Inc. (JUNS:NASDAQ) soared at $15.37, representing a gain of 33.7%. On Thu, Dec 12, 2024, JUNS:NASDAQ touched a New 2-Week High of $15.37. The stock appeared on our News Catalysts scanner on Wed, Dec 04, 2024 at 08:22 PM in the 'PUBLIC OFFERING' category. From Tue, Dec 03, 2024, the stock recorded 100.00% Up Days and 100.00% Green Days
About Jupiter Neurosciences Inc. (JUNS:NASDAQ)
Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation.
Top 10 Gainers:
- MSP Recovery Inc. (LIFW:NASDAQ), 103.77%
- Palisade Bio Inc. (PALI:NASDAQ), 68.57%
- SEALSQ Corp. (LAES:NASDAQ), 60.87%
- Himax Technologies, Inc. (HIMX:NASDAQ), 44.93%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 44.58%
- WISeKey International Holding AG (WKEY:NASDAQ), 36.67%
- MKDWELL Tech Inc. (MKDW:NASDAQ), 36.26%
- Canoo Inc. (GOEV:NASDAQ), 34.62%
- Jupiter Neurosciences Inc. (JUNS:NASDAQ), 33.65%
- UTime Limited (WTO:NASDAQ), 32.72%